| | Class 2 Device Recall Nova Stat Profile Prime Plus Analyzer |  |
| Date Initiated by Firm | September 18, 2023 |
| Date Posted | November 01, 2023 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0207-2024 |
| Recall Event ID |
93095 |
| 510(K)Number | K200403 |
| Product Classification |
Electrode, ion specific, sodium - Product Code JGS
|
| Product | Nova Biomedical Prime Plus Analyzer -Intended to measure certain gases in blood, serum, plasma or pH of blood, serum, and plasma.
(1) PN 57400 Stat Profile Prime Plus Analyzer
(2) PN 59508 Stat Profile Prime Plus Analyzer, Remanufactured |
| Code Information |
UDI-DI:
(1) 00385480574006
(2) 00385480595087
All software versions (V1.17.1123.0 and V3.2.1123.0)
|
Recalling Firm/ Manufacturer |
Nova Biomedical Corporation 200 Prospect St Waltham MA 02453-3407
|
| For Additional Information Contact | Theresa Austin 781-647-3700 |
Manufacturer Reason for Recall | Potential risk of reporting erroneous creatinine patient results associated with the initial start-up of a new BUN/Creatinine Sensor Cartridge. The potential risk is within the first 2-4 hours after cartridge installation that may not be identified by traditional Quality Control practices. |
FDA Determined Cause 2 | Process design |
| Action | Nova Biomedical Customer Success Managers starting 9/18/23 contacted consignees directly via telephone, to review the bulletin with the consignee DRP, verify an email to send the bulletin to them, and then immediately forward the bulletin to them so they can share within their own healthcare facility.
Letter states the reason for recall, health risk and action to take:
Nova Biomedical recommends that your healthcare facility take one of the following risk mitigation steps after a BUN/Creatinine Sensor Cartridge replacement to reduce the possibility of this issue occurring in your facility until your analyzers have received a software update.
" If your analyzer tests patient samples frequently, initiate a manual analyzer calibration every 30 minutes within the first 2 hours, and then every hour for the next 2 hours after cartridge replacement.
" If your analyzer tests patient samples infrequently, within the first 4 hours after cartridge replacement, initiate a manual analyzer calibration prior to performing a patient test.
Until your Prime Plus analyzer(s) software is updated, if your healthcare facility experiences an erroneous creatinine result or adverse event after a new sensor cartridge installation, Nova encourages you to contact Nova Biomedical or your authorized distributor to properly document the incident. For adverse event(s), Nova encourages you to report the details using the MedWatch Online Voluntary Reporting Form, MedWatch Online Voluntary Reporting Form (fda.gov).
INTERNAL HEALTHCARE FACILITY COMMUNICATION:
This Field Correction Notice should be distributed to all those within your organization who need to be aware of this issue. Please notify other parties affiliated with your organization, which are affected by this notice. Please maintain awareness of this notice until the issue has been corrected with a scheduled software update.
If you have any questions on the contents of this notice, would like to discuss other risk mitigation options |
| Quantity in Commerce | 1779 units: 438 US; 1341 OUS |
| Distribution | Nationwide
Foreign:
Country
Algeria
Australia
Austria
Bangladesh
Benin
Bolivia
Brazil
Canada
Chile
China
Colombia
Croatia
CYPRUS
Czech Republic
Ecuador
Egypt
El Salvador
Finland
France
Germany
Greece
Guatemala
India
Indonesia
Ireland
Israel
Italy
Japan
JORDAN
Kazakhstan
Kenya
Kurdistan, Iraq
Kuwait
Malaysia
Malta
Mexico
Moldova
Morocco
Nepal
Netherlands
New Zealand
Oman
Pakistan
Palestine
Paraguay
Paraquay
Peru
Philippines
Poland
Puerto Rico
Qatar
Republic of Panama
Romania
Russia
Rwanda
Saudi Arabia
Serbia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Thailand
Trinidad
Trinidad,W.I.
Tunisia
UK
Ukraine
United Arab Emerites
Uruguay
Vietnam
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = JGS
|
|
|
|